Allergan articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2015/05/26 05:35
2015/05/26 05:35
8h
Tawanna and Jermaine Mead have filed a federal lawsuit in New Orleans against the Irvine, Calif.-based Allergan Inc., claiming Tawanna experienced weight gain and pain after her June 25, 2010, Lap...
2015/05/26 05:35
2015/05/26 05:35
Latest videos
2015/05/26 00:21
2015/05/26 00:21
13h
Can't stop yawning? Hair going curly? The medicines with VERY odd side-effects No drug is without potential side-effects, from harmless to alarming Changes in taste are a side-effect of...
2015/05/22 17:48
2015/05/22 17:48
3d
If you could rewind back to January 2014, these are the stocks you would buy. They were the top 10 performing stocks in the S&P 500 for the year and they made a lot of people wealthy. We’ll take a...
2015/05/22 11:17
2015/05/22 11:17
4d
The global medical devices (MD) market will see a steady growth over the coming years with the sales revenue and international trade value reaching $543.9 bn and $289.2 bn respectively by 2020 driven...
2015/05/22 10:42
2015/05/22 10:42
4d
In recent years, some of the most prominent hedge fund victories have been all about health care. Larry Robbins, the billionaire founder of Glenview Capital Management, has generated excellent...
2015/05/21 23:27
2015/05/21 23:27
4d
It's that time again! The Lightning Round bell has rung, and Jim Cramer gives his take on a few favorite audience stocks: PDL BioPharma: "I see that stock has been a one-way ticket down, and I don't...
2015/05/20 12:39
2015/05/20 12:39
6d
Valeant Pharmaceuticals International Inc. is in talks to acquire one of the largest drug makers in Egypt to expand in both veterinary and human medicines, according to people with knowledge of the...
2015/05/19 16:22
2015/05/19 16:22
6d
Double Chin Drug Kybella Following Botox Lead Says Kythera CEO Kythera has high expectations for the targeted launch of its FDA-approved double chin injection Kybella in the second half of 2015, said...
2015/05/18 14:22
2015/05/18 14:22
7d
Year-to-date return: 15.2% Morgan Stanley Rating/Price Target: Overweight/$343 PT Morgan Stanley said: We believe Actavis stands at a unique cross-section between both Specialty and Major...
2015/05/16 00:09
2015/05/16 00:09
10d
William Ackman's hedge fund bought nearly 19.5 million shares of Valeant Pharmaceuticals International (VRX) , a firm he recently described as a nascent Berkshire Hathaway...
2015/05/15 21:56
2015/05/15 21:56
10d
BOSTON: Wall Street's savviest investors are picking sides on Bill Ackman's new bet on Valeant Pharmaceuticals International Inc , with BlueMountain Capital and T. Rowe Price adding money, while...
2015/05/14 14:58
2015/05/14 14:58
11d
Tim Armstrong's payout could be more than $200 million. The biggest component of the chief executive officer's package is about $120 million worth of unexercised options, some of which were granted...
2015/05/13 15:49
2015/05/13 15:49
12d
Dublin-based generic and specialty drug company Actavis plc is a pharma deal maker. Much of the company’s growth has been the result of strategic acquisitions. Originally, Actavis was known as Watson...
2015/05/12 17:42
2015/05/12 17:42
13d
It’s the You’ve Got Mail generation of stocks, a smattering of former high-flying internet, tech and growth companies that were left for dead by investors shortly after the 2000′s dot-com bust....
2015/05/11 23:22
2015/05/11 23:22
14d
Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) announced that, at shareholder meetings held today, all proposals related to Actavis' planned acquisition of Allergan were approved by both...
2015/05/11 22:50
2015/05/11 22:50
14d
Greece's finances and slowing Chinese growth weighed on investors' minds leading to a lower finish across the board. Oil prices fell, pushing down energy stocks like Exxon Mobil and Chevron. BNP...
2015/05/11 22:50
2015/05/11 22:50
14d
... market seems to be tired," said Peter Cardillo, chief market economist at Rockwell Global Capital. Photo: AP US stocks have finished lower, snapping a two-day surge in equities as investors...
2015/05/11 22:27
2015/05/11 22:27
14d
Then Actavis bid on Valeant, making it the biggest acquisition of 2014. With these smart acquisitions, Cramer still thinks this is the cheapest big pharma company on Earth—and the run is far from over...
2015/05/11 21:48
2015/05/11 21:48
14d
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: Noble Energy Inc., down $3.05 to $46.07 The energy company will...
2015/05/11 17:17
2015/05/11 17:17
14d
WAYNE, Pa.--(BUSINESS WIRE)--Pennsylvania Bio, the statewide trade association representing the commonwealth’s life sciences industry, announced today the appointment of Marc S. Malandro, PhD, CLP,...
2015/05/26 05:35
2015/05/26 05:35
Latest from Twitter